VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 83 filers reported holding VAXCYTE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $848 | +14.9% | 16,641 | +12.6% | 0.09% | -31.3% |
| Q2 2023 | $738 | +16.2% | 14,778 | -12.8% | 0.13% | +54.0% |
| Q1 2023 | $635 | +80.9% | 16,955 | +131.7% | 0.09% | +64.2% |
| Q4 2022 | $351 | -99.9% | 7,318 | -40.3% | 0.05% | +17.8% |
| Q3 2022 | $294,000 | +13.5% | 12,258 | +2.9% | 0.04% | -2.2% |
| Q2 2022 | $259,000 | -65.4% | 11,910 | -57.8% | 0.05% | -49.5% |
| Q4 2020 | $749,000 | – | 28,191 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $99,174,000 | 24.03% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $44,903,000 | 11.24% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,111,485 | $26,442,000 | 11.06% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $54,944,000 | 4.23% |
| Kynam Capital Management, LP | 211,483 | $5,031,000 | 2.69% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,895,000 | 2.64% |
| Ghost Tree Capital, LLC | 250,000 | $5,948,000 | 2.13% |
| RA Capital Management | 4,240,464 | $100,881,000 | 1.78% |
| Opaleye Management Inc. | 315,800 | $7,513,000 | 1.59% |
| Ikarian Capital, LLC | 295,111 | $7,021,000 | 1.05% |